PLX CIK: 1006281

Protalix BioTherapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.0
FY22:
28.0
FY23:
42.5
FY24:
29.1
FY25:
25.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.5
FY22:
−13.0
FY23:
10.5
FY24:
3.92
FY25:
−5.50
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.9
FY22:
−10.8
FY23:
12.9
FY24:
6.52
FY25:
−2.95
(positive)
Change from FY21 to FY25
millions USD
FY21:
−27.6
FY22:
−14.4
FY23:
8.57
FY24:
4.15
FY25:
−5.61
(positive)
Change from FY21 to FY25
millions USD
FY21:
−27.6
FY22:
−14.9
FY23:
8.31
FY24:
2.93
FY25:
−6.60

All amounts in millions USD Data sources:SEC EDGARTwelve Data